Norcal Carcinet Support Group

Nonprofit profile at a glance

EIN
452968919
IRS 990-EZ coverage
2018–2025
Forms available
Form 990 2021, Form 990-EZ 2025, Form 990-N 2017
Location
Oakland, CA, USA
Rating
58
Verdict
MIXED
Rating confidence
Moderate
Sector
Heart and Circulatory System Diseases, Disorders

Reported finances

Revenue
$126,948
Expenses
$37,058
Assets
$453,468

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

7 people listed

Executive titles in this filing

  • Josh Mailman (President Secretary)

People named in this filing

  • Josh Mailman (President Secretary)
  • Geneva Hayes (Treasure)
  • Elizabeth Magee (Director)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Our mission is to help those with neuroendocrine tumors and carcinoid to share challenges and experiences learn about prognosis and treatments find information and improve communications between the medical community patients and caregivers.

What it reported doing in 2025

Anocora. - Development of a Neuroendocrine Clinical Trial Finder - The finder has launched and has been used by over 1,000 individuals

Operating model

Revenue model
Mixed. Its operating money came from several sources; no one source provided a clear majority.
Distribution model
Grant intermediary. The nonprofit sent 100% of its reported program spending out as grants.

The verdict

MIXED - The filed numbers largely add up and revenue comfortably covers expenses. A relatively small share of available resources goes toward mission work and revenue has declined or grown slowly.

Rating breakdown

  • Financial Efficiency: 37
  • Transparency & Controls: 82
  • Sustainability: 82
  • Growth: 60

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 20.4%; rating input score 20
  • Program expense ratio: 64.8%; rating input score 65

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: 70.8%; rating input score 97; 97th percentile among comparable filings
  • Total-asset coverage ratio: 12.24; rating input score 99; 99th percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 0%; rating input score 63; 63rd percentile among comparable filings

Growth

  • Program expense growth: 13.8% per year; rating input score 100; 66th percentile among comparable filings
  • Revenue growth: -7.4% per year; rating input score 0; 6th percentile among comparable filings
  • Asset growth: 15% per year; rating input score 100; 70th percentile among comparable filings

Details

  • Where the money goes: 20.4% of revenue deployed · 64.8% of spending went to programs
  • Governance: Filed governance answers
  • Accomplishments: 3 filed program accomplishments · $24K in reported program spending
  • Leadership: top reported pay $0 · 7 people listed
  • Consistency: 7 of 7 current checks pass
  • Schedules: 2 filed schedules
  • Filing history: 7 filing years from 2018 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Mission deployment rate scored 20/100.
  • High — Growth: Revenue growth scored 0/100.